Sort
261,768 grants matching “gene therapy”
Defining HIV sanctuary sites during autologous and allogeneic transplantation
$894,352Leslie S Kean · University Of Southern California · U19 · FY2016 · HL
Defining HIV sanctuary sites during autologous and allogeneic transplantation
$894,352Leslie S Kean · University Of Southern California · U19 · FY2019 · HL
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$894,296John F Dipersio · Washington University · R35 · FY2023 · CA
Center for Clinical and Translational Sciences (CCTS)
$894,240David D McPherson · University Of Texas Hlth Sci Ctr Houston · KL2 · FY2016 · TR
Targeting B-cell lymphoma with Leukothera-phase II
$894,222Benjamin A Belinka · Actinobac Biomed, Inc. · R42 · FY2015 · CA
Genetic Analysis of Neurodegeneration
$894,043Mel B Feany · Brigham And Women'S Hospital · R35 · FY2024 · NS
Structure, function, and regulation of the bacterial transcription cycle
$893,989Seth A Darst · Rockefeller University · R35 · FY2021 · GM
Epidemiology of putative genuine genetic variant: The Women's Health Intiative
$893,905Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2012 · HG
Longitudinal Cognitive ERP studies: Advancement for AD Clinical Trials
$893,896John M Olichney · University Of California At Davis · R01 · FY2015 · AG
VERITY: Value and Evidence in Rheumatology using bioInformaTics, and advanced analYtics
$893,894Daniel Hal Solomon · Brigham And Women'S Hospital · P30 · FY2020 · AR
Development of CA-IL-12 for Triple Negative Breast Cancer
$893,673Edward J Filardo · Cytonus Therapeutics, Inc. · R44 · FY2024 · CA
Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid Arthritis
$893,652Katherine Phoenix Liao · Brigham And Women'S Hospital · R01 · FY2016 · HL
Role of ASIC3 in the Etiology of Fibromyalgia
$893,569Kathleen A Sluka · University Of Iowa · R01 · FY2009 · AR
THE GENETICS OF VULNERABILITY TO NICOTINE ADDICTIONS
$893,543Pamela Ann Madden · Washington University · R01 · FY2009 · DA
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV
$893,519Pamela J Skinner · University Of Minnesota · R01 · FY2025 · MH
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV
$893,519Pamela J Skinner · University Of Minnesota · R01 · FY2023 · MH
Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV
$893,519Pamela J Skinner · University Of Minnesota · R01 · FY2024 · MH
Functional Analysis of Oncogenic Networks in Primary Organoids
$893,517Calvin J Kuo · Stanford University · U01 · FY2014 · CA
RECONSTITUTION OF CMV IMMUNITY IN HIV-INFECTED HOSTS
$893,465Fred Hutchinson Cancer Research Center · R01 · FY2000 · AI
Developing Durable, Env-Boosted CAR T Cells for HIV Cure
$893,464Christopher W Peterson · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
Institute of Human Virology Clinical Trials Unit
$893,454William Albert Blattner · University Of Maryland Baltimore · U01 · FY2009 · AI
Prevention of Graft-Versus-Host-Disease in the Era of Adoptive Immunotherapy
$893,343Marie Bleakley · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA
National Gene Vector Biorepository and Coordinating Center at Indiana University
$893,258Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2016 · HL
National Gene Vector Biorepository and Coordinating Center at Indiana University
$893,258Kenneth G Cornetta · Indiana University Indianapolis · P40 · FY2017 · HL
MULTIPURPOSE ARTHRITIS &MUSCULOSKELETAL DISEASES CENTER
$893,240University Of North Carolina Chapel Hill · P60 · FY2001 · AR